Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.76 |
| ▸ | HPGD | P15428 | 2/20 | 0.76 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.76 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.76 |
| ▸ | ABAT | P80404 | 1/20 | 0.76 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.76 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.57 |
| ▸ | XDH | P47989 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.53 |
| ▸ | AR | P10275 | 1/20 | 0.53 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vanillin SCHEMBL5529254 | 0.88 | ALDH1A1 (0.71) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL44060 | 0.87 | ALDH1A1 (0.86) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL720723 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL29354839 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL1213 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL27673973 | 0.85 | ALDH1A1 (0.89) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL19260053 | 0.85 | ALDH1A1 (0.96) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL20549709 | 0.85 | ALDH1A1 (0.96) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL19149274 | 0.85 | ALDH1A1 (0.96) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 | |
| Vanillin SCHEMBL11269339 | 0.85 | ALDH1A1 (0.96) | ALDH1A1TDP1HPGDTRIM24ALDH5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115975833-B | Saccharomyces cerevisiae recombinant strain for producing vanillin and construction method thereof | 厦门大学 | 2024-07-12 | — | — | CN | disclosed |
| US-20230183159-A1 | METHOD FOR THE TREATMENT OF A COMPOSITION COMPRISING NATURAL VANILLIN | SPECIALTY OPERATIONS FRANCE (FR) | 2023-06-15 | — | — | US | disclosed |
| CN-115975833-A | Saccharomyces cerevisiae recombinant strain for producing vanillin and construction method thereof | 厦门大学 | 2023-04-18 | — | — | CN | disclosed |
| US-20070231864-A1 | Vanillin production | DAVID MICHAEL & CO., INC. | 2007-10-04 | — | — | US | disclosed |
| US-7226783-B1 | Vanillin production | DAVID MICHAEL & CO., INC. (US) | 2007-06-05 | — | — | US | disclosed |
| US-20070044174-A1 | Vanillin production | DAVID MICHAEL & CO., INC. (US) | 2007-02-22 | — | — | US | disclosed |
| WO-2003071861-A2 | VANILLIN BIOSYNTHETIC PATHWAY ENZYME FROM VANILLA PLANIFOLIA | DAVID MICHAEL & CO., INC. (US) | 2003-09-04 | — | — | WO | disclosed |
| US-20030070188-A1 | Vanillin biosynthetic pathway enzyme from Vanilla planifolia | DAVID MICHAEL & CO., INC. | 2003-04-10 | — | — | US | disclosed |
| EP-1012235-A4 | IMPROVED VANILLIN PRODUCTION | DAVID MICHAEL & CO INC (US) | 2002-07-31 | — | — | EP | disclosed |
| EP-1012235-A1 | IMPROVED VANILLIN PRODUCTION | David Michael & CO., Inc. (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999003975-A1 | IMPROVED VANILLIN PRODUCTION | DAVID MICHAEL & CO., INC. (US) | 1999-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183159-A1 | METHOD FOR THE TREATMENT OF A COMPOSITION COMPRISING NATURAL VANILLIN | SDHA, COMT, NDUFV2 | ALDH1A1 189/4885TDP1 3517/4885HPGD 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.